St. Francis predicts X-Stop launch in mid-2005
This article was originally published in The Gray Sheet
Executive Summary
FDA-requested information to support approval for firm's X-Stop non-fusion lumbar device is "reasonable" and "readily available," President & CEO Kevin Sidow states. St. Francis will submit the requested data quickly, he says. In September, FDA's Orthopaedic & Rehabilitation Devices Panel voted 5-3 against approval of the device, which is meant to treat lumbar spinal stenosis, due to a lack of radiographic data proving reduction of stenosis-induced pressure on spinal nerve roots (1"The Gray Sheet" Sept. 6, 2004, p. 7). Sidow believes X-Stop is on track for a mid-2005 release in the U.S. Currently, the device is approved in Europe and Japan...
You may also be interested in...
FDA Panel Doubts Lumbar Fusion Alternative’s Imaging Data
St. Francis Medical should collect more detailed radiographic data of its X-Stop non-fusion lumbar device to prove reduction of stenosis-induced pressure on spinal nerve roots, FDA panelists urged Aug. 31
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.